Literature DB >> 7477446

Evidence that BKCa channel activation contributes to K+ channel opener induced relaxation of the porcine coronary artery.

J L Balwierczak1, C M Krulan, H S Kim, D DelGrande, G B Weiss, S Hu.   

Abstract

The rank order of potency of a series of benzopyran and cyanoguanidine K+ channel openers (KCOs) for causing relaxation of the PGF2 alpha-precontracted porcine coronary artery was determined. Glyburide, an inhibitor of KATP channels, showed an apparent competitive inhibition of the vasorelaxant activity of the KCOs. The pA2 values of glyburide when cromakalim and CGP 14877 (P1060) were used as vasorelaxants were 7.66 and 7.83, respectively. Charybdotoxin (40 nM), an inhibitor of BKCa channels, also caused a significant inhibition of the cromakalim mediated relaxation of the porcine coronary artery. In order to clarify the site of action of these KCOs, we identified a K+ channel current in single porcine coronary arterial cells and measured channel activity in the presence of these compounds. The prominent K+ ion current in these cells had characteristics typical of the conventional large Ca(2+)-activated K+ channel (BKCa) present in other smooth muscle cells. Using symmetrical K+ concentrations, the channel had a conductance of 214 pS and was found to be sensitive to [Ca2+]i and membrane potential. The KCOs were found to reversibly increase the open probability (P(o)) of the channel without changing channel conductance. The potency of the KCOs to increase K+ channel opening was similar to the potency of these compounds to cause coronary artery relaxation. These results indicate that the porcine coronary artery contains the BKCa channel and that this channel, along with other types of K+ channels (KATP), mediate the vasorelaxant effects of K+ channel openers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477446     DOI: 10.1007/bf00176777

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.

Authors:  S L Hu; H S Kim; P Okolie; G B Weiss
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

2.  A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalim.

Authors:  C H Gelband; N J Lodge; C Van Breemen
Journal:  Eur J Pharmacol       Date:  1989-08-22       Impact factor: 4.432

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium".

Authors:  G Isenberg; U Klockner
Journal:  Pflugers Arch       Date:  1982-10       Impact factor: 3.657

5.  ATP suppresses activity of Ca(2+)-activated K+ channels by Ca2+ chelation.

Authors:  U Klöckner; G Isenberg
Journal:  Pflugers Arch       Date:  1992-01       Impact factor: 3.657

6.  Nicorandil opens a calcium-dependent potassium channel in smooth muscle cells of the rat portal vein.

Authors:  S Kajioka; M Oike; K Kitamura
Journal:  J Pharmacol Exp Ther       Date:  1990-09       Impact factor: 4.030

7.  Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.

Authors:  G H Gelband; J R McCullough
Journal:  Am J Physiol       Date:  1993-05

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  A target K+ channel for the LP-805-induced hyperpolarization in smooth muscle cells of the rabbit portal vein.

Authors:  M Kamouchi; S Kajioka; T Sakai; K Kitamura; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

10.  Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein.

Authors:  T C Hamilton; S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

View more
  5 in total

1.  Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels.

Authors:  Vincenzo Calderone; Silvio Chericoni; Cinzia Martinelli; Lara Testai; Antonio Nardi; Ivano Morelli; Maria Cristina Breschi; Enrica Martinotti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-17       Impact factor: 3.000

2.  Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels.

Authors:  Vincenzo Calderone; Alma Martelli; Lara Testai; Enrica Martinotti; Maria C Breschi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-04       Impact factor: 3.000

Review 3.  Targeting BKCa Channels in Migraine: Rationale and Perspectives.

Authors:  Mohammad Al-Mahdi Al-Karagholi; Christian Gram; Cherie Amalie Waldorff Nielsen; Messoud Ashina
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

4.  Functional and molecular identification of a TASK-1 potassium channel regulating chloride secretion through CFTR channels in the shark rectal gland: implications for cystic fibrosis.

Authors:  Connor J Telles; Sarah E Decker; William W Motley; Alexander W Peters; Ali Poyan Mehr; Raymond A Frizzell; John N Forrest
Journal:  Am J Physiol Cell Physiol       Date:  2016-09-21       Impact factor: 4.249

5.  Significance of K(ATP) channels, L-type Ca²⁺ channels and CYP450-4A enzymes in oxygen sensing in mouse cremaster muscle arterioles in vivo.

Authors:  Anh Thuc Ngo; Mads Riemann; Niels-Henrik Holstein-Rathlou; Christian Torp-Pedersen; Lars Jørn Jensen
Journal:  BMC Physiol       Date:  2013-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.